Treating Crohn’s Disease With Medical Marijuana in Mississippi

Medical marijuana patients in Mississippi who are suffering from Crohn’s disease have claimed considerable improvements in their condition. In Mississippi, where medical marijuana is legal, patients report feeling substantially less suffering since its use was legalized. Cannabinoids in cannabis have been demonstrated to reduce gastrointestinal distress in a variety of ways. Crohn’s disease sufferers have also reported an increase in appetite.

The digestive system is just one of many systems that have historically benefited from cannabis’s traditional use as a medicine. Cannabinoids are thought to be responsible for the plant’s beneficial effects, as they act as an external supplement by inhibiting a number of metabolic processes.

Increased immune activity, associated with gastric inflammation, was observed in preclinical studies of cannabinoid receptor loss, cannabinoid receptor antagonists (blockers), and a lower number of endocannabinoids, lending credence to the hypothesis that cannabis may benefit those with Crohn’s Disease.

The gut microbiota, immune cells, and functional epithelium are all influenced by the endocannabinoid system, which is composed of cannabinoids, their receptors, and metabolic enzymes. Together, these factors lower gastrointestinal inflammation.

Medical cannabis has been demonstrated to offer promising results in treating Crohn’s disease, according to a number of separate trials and will be available to patients in Mississippi who have a legal medical marijuanas card, and purchase their medical marijuanas from a licensed Mississippi dispensary.